Literature DB >> 16611651

Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis.

H Kunst1, M Wickremasinghe, A Wells, R Wilson.   

Abstract

The aim of the present study was to determine whether patients with bronchiectasis and nontuberculous mycobacteria (NTM) have a higher prevalence of Aspergillus-related lung disease. A series of 30 consecutive patients with bronchiectasis and NTM (cases) were compared with 61 patients with bronchiectasis and no evidence of NTM (controls). Aspergillus serology and computerised tomography of the thorax were used to identify Aspergillus-related lung diseases, including aspergilloma, allergic bronchopulmonary aspergillosis and chronic necrotising pulmonary aspergillosis. The rate of positive Aspergillus serology was higher in cases with NTM disease compared with controls (10 out of 30 versus six out of 61). The radiological features of Aspergillus-related lung disease were also more common among patients with NTM disease than controls (six out of 30 versus none out of 61). This association between NTM disease and Aspergillus-related lung disease remained significant after adjustment for confounding effects of age and lung function (adjusted odds ratio 5.1, 95% confidence interval 1.5-17.0). Patients with bronchiectasis and nontuberculous mycobacterial disease have a higher prevalence of coexisting Aspergillus-related lung disease than patients with bronchiectasis and without nontuberculous mycobacteria. Identification of Aspergillus-related lung disease is important as prognosis amongst undetected cases is invariably poor.

Entities:  

Mesh:

Year:  2006        PMID: 16611651     DOI: 10.1183/09031936.06.00139005

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

Review 1.  Surgical management of non-cystic fibrosis bronchiectasis.

Authors:  Miyako Hiramatsu; Yuji Shiraishi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 2.  Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents.

Authors:  Jonathan Ilowite; Peter Spiegler; Heather Kessler
Journal:  Drugs       Date:  2009       Impact factor: 9.546

3.  Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients.

Authors:  Ji Young Kang; Jick Hwan Ha; Hye Seon Kang; Hyoung-Kyu Yoon; Hee-Je Kim; Seok Lee; Dong-Gun Lee; Jung Im Jung; Seok Chan Kim; Young Kyoon Kim
Journal:  Int J Hematol       Date:  2015-02-08       Impact factor: 2.490

4.  Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection.

Authors:  Seong Mi Moon; Hye Yun Park; Byeong-Ho Jeong; Kyeongman Jeon; Soo-Youn Lee; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

Review 5.  Respiratory Mycoses in COPD and Bronchiectasis.

Authors:  Pei Yee Tiew; Micheál Mac Aogáin; Soo Kai Ter; Stefano Aliberti; James D Chalmers; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2021-03-11       Impact factor: 2.574

6.  An Uncommon Cause of Bronchial Obstruction.

Authors:  John W Frey; Charles D Bengtson; Nirmal K Veeramachaneni; Kyle R Brownback
Journal:  Ann Am Thorac Soc       Date:  2020-11

7.  Mycobacterium avium intracellulare infection complicated by allergic bronchopulmonary aspergillosis in a non-asthmatic patient.

Authors:  Arun Kadamkulam Syriac; Gurveen Malhotra; Cristina Isabel Anez de Gomez; Ahmet S Copur
Journal:  BMJ Case Rep       Date:  2018-05-26

8.  Clinical significance of Aspergillus species isolated from respiratory specimens in patients with Mycobacterium avium complex lung disease.

Authors:  K Furuuchi; A Ito; T Hashimoto; S Kumagai; T Ishida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-17       Impact factor: 3.267

Review 9.  Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways.

Authors:  Sanjay H Chotirmall; Maria Teresa Martin-Gomez
Journal:  Mycopathologia       Date:  2017-05-17       Impact factor: 2.574

10.  Performance of RGM Medium for Isolation of Nontuberculous Mycobacteria from Respiratory Specimens from Non-Cystic Fibrosis Patients.

Authors:  Suwatchareeporn Rotcheewaphan; Oluwadamilola E Odusanya; Christina M Henderson; Dominic Stephenson; Kenneth N Olivier; John D Perry; Adrian M Zelazny
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.